Hypofractionated Postmastectomy Radiation Therapy.


Journal

Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247

Informations de publication

Date de publication:
Historique:
received: 25 05 2020
revised: 21 10 2020
accepted: 09 11 2020
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 26 1 2021
Statut: epublish

Résumé

To provide an overview of the major randomized trials that support the use of hypofractionated post-mastectomy radiation therapy for locally advanced breast cancer patients. PubMed was systematically reviewed for publications reporting use of of hypofractionated radiation therapy in patients requiring post-mastectomy radiation. Standard fractionation, which is typically delivered over 5 to 7 weeks, is considered the standard of care in setting of post-mastectomy radiation therapy (PMRT). Modern data has helped to establish hypofractionated whole breast irradiation, which consists of a 3- to 4-week regimen, as a new standard of care for early-stage breast cancer. Hypofractionated whole breast irradiation has also laid the groundwork for the exploration of a hypofractionated approach in the setting of hypofractionated post-mastectomy radiation therapy. While standard fractionation remains the most commonly utilized regimen for PMRT, recently published trials support the safety and efficacy of a hypofractionated approach. Ongoing trials are further investigating the use of hypofractionated PMRT.

Identifiants

pubmed: 33490735
doi: 10.1016/j.adro.2020.11.003
pii: S2452-1094(20)30348-1
pmc: PMC7809517
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100618

Informations de copyright

© 2020 The Authors.

Références

J Reconstr Microsurg. 2004 Feb;20(2):149-52
pubmed: 15011123
Br J Radiol. 1985 Jun;58(690):515-28
pubmed: 4063711
Pract Radiat Oncol. 2016 Jul-Aug;6(4):e81-e88
pubmed: 26723552
J Surg Oncol. 2015 Oct;112(5):458-64
pubmed: 26345465
Lancet Oncol. 2013 Oct;14(11):1086-1094
pubmed: 24055415
Br J Radiol. 1989 Aug;62(740):679-94
pubmed: 2670032
Plast Reconstr Surg. 2013 Mar;131(3):320e-326e
pubmed: 23446580
N Engl J Med. 2002 Oct 17;347(16):1227-32
pubmed: 12393819
Radiother Oncol. 1996 Oct;41(1):7-13
pubmed: 8961362
Plast Reconstr Surg. 2014 Oct;134(4):588-595
pubmed: 25357021
Breast J. 2020 Jan;26(1):11-16
pubmed: 31865619
Asia Pac J Oncol Nurs. 2018 Jan-Mar;5(1):107-113
pubmed: 29379842
Plast Reconstr Surg. 2014 Jul;134(1):1e-10e
pubmed: 25028850
Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):99-104
pubmed: 10219801
Pract Radiat Oncol. 2018 May - Jun;8(3):145-152
pubmed: 29545124
Acta Oncol. 2006;45(3):280-4
pubmed: 16644570
Breast. 2010 Jun;19(3):192-7
pubmed: 20511069
Clin Oncol (R Coll Radiol). 1995;7(2):93-6
pubmed: 7619770
Plast Reconstr Surg. 2019 Nov;144(5):743e-750e
pubmed: 31688748
Ann Plast Surg. 2013 Aug;71(2):149-55
pubmed: 23542828
Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):133-8
pubmed: 2912934
Breast J. 2020 Feb;26(2):176-181
pubmed: 31531930
Lancet. 1999 May 15;353(9165):1641-8
pubmed: 10335782
Lancet Oncol. 2006 Jun;7(6):467-71
pubmed: 16750496
Radiother Oncol. 2005 Apr;75(1):9-17
pubmed: 15878095
Breast Care (Basel). 2016 Oct;11(5):328-332
pubmed: 27920625
Ann Surg. 2008 Jun;247(6):1019-28
pubmed: 18520230
Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:228-232
pubmed: 29678414
J Med Imaging Radiat Oncol. 2010 Jun;54(3):229-34
pubmed: 20598011
Int J Radiat Oncol Biol Phys. 1990 Nov;19(5):1131-3
pubmed: 2254102
Plast Reconstr Surg. 2002 May;109(6):1919-24; discussion 1925-6
pubmed: 11994594
Radiother Oncol. 2011 Aug;100(2):282-8
pubmed: 21367477
N Engl J Med. 2002 Oct 17;347(16):1233-41
pubmed: 12393820
Radiat Oncol. 2020 Jan 17;15(1):17
pubmed: 31952507
Lancet. 2008 Mar 29;371(9618):1098-107
pubmed: 18355913
Br Med J. 1966 Apr 2;1(5491):834-7
pubmed: 20790877
Asian Pac J Cancer Prev. 2020 Jan 01;21(1):119-125
pubmed: 31983173
JAMA. 2014 Dec 17;312(23):2542-50
pubmed: 25494006
Radiother Oncol. 2004 Jun;71(3):297-301
pubmed: 15172145
Lancet Oncol. 2008 Apr;9(4):331-41
pubmed: 18356109
J Natl Cancer Inst. 2005 Jan 19;97(2):116-26
pubmed: 15657341
N Engl J Med. 2010 Feb 11;362(6):513-20
pubmed: 20147717
N Engl J Med. 1997 Oct 2;337(14):956-62
pubmed: 9309100
Breast Cancer Res Treat. 2014 Jul;146(2):299-308
pubmed: 24951266
J Natl Cancer Inst. 2017 Nov 1;109(11):
pubmed: 29059428
Lancet Oncol. 2018 Nov;19(11):1516-1529
pubmed: 30337220
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Radiother Oncol. 2018 Jan;126(1):155-162
pubmed: 29153463
J Clin Oncol. 2017 Jun 20;35(18):2037-2043
pubmed: 28459606
Med Oncol. 2012 Dec;29(4):2570-6
pubmed: 22354766
Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):287-295
pubmed: 27986343
Ann Plast Surg. 2010 May;64(5):679-83
pubmed: 20395800
Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):136-42
pubmed: 12909226
Lancet Oncol. 2019 Mar;20(3):352-360
pubmed: 30711522
Radiother Oncol. 1990 Jul;18(3):213-20
pubmed: 2217869
Breast J. 2020 Jan;26(1):47-54
pubmed: 31944484
J Med Imaging Radiat Oncol. 2015 Apr;59(2):243-7
pubmed: 25287654
Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):745-50
pubmed: 11020571
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):694-700
pubmed: 32289474
Breast J. 2013 Mar-Apr;19(2):162-7
pubmed: 23294184
Lancet. 2014 Jun 21;383(9935):2127-35
pubmed: 24656685
J Surg Oncol. 2016 Jun;113(8):891-4
pubmed: 26876921
N Engl J Med. 1997 Oct 2;337(14):949-55
pubmed: 9395428
Plast Reconstr Surg. 2013 Jan;131(1):15-23
pubmed: 23271515
Br J Radiol. 1988 Jul;61(727):625-30
pubmed: 3044476
Lancet Oncol. 2010 Mar;11(3):231-40
pubmed: 20138809
Pract Radiat Oncol. 2020 Jul - Aug;10(4):e244-e249
pubmed: 31704234
Int J Radiat Oncol Biol Phys. 1982 Jul;8(7):1143-53
pubmed: 7118617

Auteurs

Mutlay Sayan (M)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.

Zeinab Abou Yehia (ZA)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.

Nisha Ohri (N)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.

Bruce G Haffty (BG)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.

Classifications MeSH